IMMEDIATE VITRECTOMY vs TAP AND INJECT IN EYES WITH ACUTE POSTCATARACT ENDOPHTHALMITIS AND VISUAL ACUITY ≥HM: A Randomized Clinical Trial
- PMID: 36791396
- DOI: 10.1097/IAE.0000000000003759
IMMEDIATE VITRECTOMY vs TAP AND INJECT IN EYES WITH ACUTE POSTCATARACT ENDOPHTHALMITIS AND VISUAL ACUITY ≥HM: A Randomized Clinical Trial
Abstract
Purpose: To compare the outcomes of immediate pars plana vitrectomy (PPV) and tap and inject in eyes with postcataract surgery endophthalmitis.
Methods: Patients presenting with acute postcataract surgery endophthalmitis and visual acuity between ≥ hand movement and <6/18 were randomized to receive either PPV (Group A) or tap and inject (Group B).
Results: There were 26 and 31 eyes in Group A and Group B, respectively. The final mean visual acuity at 6 weeks [0.14 (Snellen equivalent 6/7.5) versus 0.22 (Snellen equivalent 6/9.5) LogMAR in Groups A and B, respectively; P = 0.2] was similar. However, eyes in Group A had significantly greater mean letter gain in vision compared with Group B (66.36 vs. 43.36, P = 0.02), and more eyes in Group A (88%) than in Group B (65%) attained a visual acuity of ≥ 6/18 ( P = 0.06). Eyes in Group B needed more reinterventions including delayed vitrectomy after tap and inject than those in Group A (39% vs. 8%; P = 0.09). On subgroup analysis, the mean visual acuity at the final follow-up was significantly better in the immediate PPV group compared with the delayed PPV group ( P = 0.04).
Conclusion: PPV resulted in earlier recovery, lesser interventions, and greater change in visual acuity than tap and inject in eyes with postcataract surgery endophthalmitis presenting with visual acuity of ≥HM.
Conflict of interest statement
No potential conflict of interest was reported by the authors.
References
-
- Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomised trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479–1496.
-
- Kuhn F, Gini G. Ten years after. Are findings of the Endophthalmitis Vitrectomy Study still relevant today?. Graefe's Archive Clin Exp Ophthalmol 2005;243:1197–1199.
-
- Fujii GY, De Juan E Jr, Humayun MS, et al. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery1 1The new Transconjunctival Sutureless Vitrectomy System is disclosed to Bausch & Lomb Surgical, St. Louis, MO. The Microsurgery Advanced Design Laboratory (MADLAB) may receive royalties related to the sale of this and other instruments mentioned in the article. Ophthalmology 2002;109:1814–1820.
-
- Crosby NJ, Westcott M, Michael E, et al. Comparative outcomes of primary vitrectomy versus tap and inject for endophthalmitis following phacoemulsification cataract surgery. Ocul Immunol Inflamm 2020;15:1–7.
-
- Tabatabaei SA, Aminzade S, Ahmadraji A, et al. Early and complete vitrectomy versus tap and inject in acute post-cataract surgery endophthalmitis presenting with hand motion vision; a quasi-experimental study. BMC Ophthalmol 2022;22:16.